Ken Fisher’s Cardlytics CDLX Stock Holding History

Ken Fisher’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-217	Closed	-$238K	–	935
2021 Q1	$238K	Sell	217 -7	-3%	-$9.24K	﹤0.01%	834
2020 Q4	$320K	Buy	+224	New	+$239K	﹤0.01%	779

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Ken Fisher's CDLX Position: Q2 2021 in Review

Ken Fisher sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 217 shares — an estimated $238K sold.

Ken Fisher first reported a position in CDLX in Q4 2020 and held it in 2 quarters. The position peaked at $320K in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

Ken Fisher reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
Ken Fisher sold 217 Cardlytics shares in Q2 2021, an estimated $238K.
Ken Fisher first reported a position in Cardlytics in Q4 2020 and held it in 2 quarters.
Ken Fisher's Cardlytics position peaked at $320K in Q4 2020.
189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.